Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Thinner needles (31 gauge) cause less discomfort but may require slower injection
Tirzepatide is an FDA- and EMA-approved dual GIP/GLP-1 receptor agonist with multiple completed Phase 3 trials behind it
Supplied as lyophilised powder, third-party tested, lab certificate published on this page
chronic), the underlying cause, imaging or biopsy results, current pancreatic enzyme levels, and whether you experience ongoing symptoms like pain or digestive problems
Instead of receiving your full prescribed dose, you might be getting 70 or 80 percent of the intended amount
Switching is possible under UK medical supervision
US$ 26.06
US$ 28.17
US$ 21.33
US$ 29.52
